trending Market Intelligence /marketintelligence/en/news-insights/trending/fmzfwaeeryrz7u4yxqwd7q2 content esgSubNav
In This List

VTv Therapeutics secures $2.5M investment

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


VTv Therapeutics secures $2.5M investment

High Point, N.C.-based vTv Therapeutics Inc. received a $2.5 million investment from MacAndrews & Forbes Group LLC.

The drug developer exercised its right — part of a July 30 agreement — to have the investor acquire 1,879,699 of its class A common shares at $1.33 each.

VTv Therapeutics discovers, develops and sells orally administered small molecule drug candidates.